Cargando…

Treatment of Intestinal Inflammation With Epicutaneous Immunotherapy Requires TGF-β and IL-10 but Not Foxp3(+) Tregs

Background: Inflammatory bowel disease (IBD) involves an increase in T effector cells in the intestines that disrupts the normal balance with T regulatory cells (Tregs). A therapy that restores this balance has the potential to treat IBD. We have shown that epicutaneous exposure to OVA induces Tregs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Xin, Berin, M. Cecilia, Gillespie, Virginia L., Sampson, Hugh A., Dunkin, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7952322/ https://www.ncbi.nlm.nih.gov/pubmed/33717186 http://dx.doi.org/10.3389/fimmu.2021.637630

Ejemplares similares

Triclosan promotes epicutaneous sensitization to peanut in mice
por: Tobar, Steven, et al.
Publicado: (2016)

Recent advances in epicutaneous immunotherapy and potential applications in food allergy
por: Hervé, Pierre-Louis, et al.
Publicado: (2023)

PDL2(+) CD11b(+) dermal dendritic cells capture topical antigen through hair follicles to prime LAP(+) Tregs
por: Tordesillas, Leticia, et al.
Publicado: (2018)

Epicutaneous immunotherapy protects cashew‐sensitized mice from anaphylaxis
por: Pelletier, Benjamin, et al.
Publicado: (2020)

Antigen Uptake by Langerhans Cells Is Required for the Induction of Regulatory T Cells and the Acquisition of Tolerance During Epicutaneous Immunotherapy in OVA-Sensitized Mice
por: Dioszeghy, Vincent, et al.
Publicado: (2018)

Gata3 hypermethylation and Foxp3 hypomethylation are associated with sustained protection and bystander effect following epicutaneous immunotherapy in peanut‐sensitized mice
por: Mondoulet, L., et al.
Publicado: (2018)

Epicutaneous Immunotherapy for Aeroallergen and Food Allergy
por: Senti, Gabriela, et al.
Publicado: (2013)

Innovative delivery systems for epicutaneous immunotherapy
por: Wang, Zhen, et al.
Publicado: (2023)

The small intestine epithelium exempts Foxp3+ Tregs from their IL-2 requirement for homeostasis and effector function
por: Prakhar, Praveen, et al.
Publicado: (2021)

Transitioning from epicutaneous to oral peanut immunotherapy
por: Wong, Lauren, et al.
Publicado: (2023)

Reduction in peanut reaction severity during oral challenge after 12 months of epicutaneous immunotherapy
por: Bégin, Philippe, et al.
Publicado: (2021)

Innovative Systems to Deliver Allergen Powder for Epicutaneous Immunotherapy
por: Wang, Yensheng, et al.
Publicado: (2021)

The Role of Regulatory T Cells in Epicutaneous Immunotherapy for Food Allergy
por: Liu, Guirong, et al.
Publicado: (2021)

CD45Rb-low effector T cells require IL-4 to induce IL-10 in FoxP3 Tregs and to protect mice from inflammation
por: Jones, Mark B., et al.
Publicado: (2019)

Epicutaneous Immunotherapy Compared with Sublingual Immunotherapy in Mice Sensitized to Pollen (Phleum pratense)
por: Mondoulet, Lucie, et al.
Publicado: (2012)

Efficacy and safety of peanut epicutaneous immunotherapy in patients with atopic comorbidities
por: Davis, Carla M., et al.
Publicado: (2022)

Magnesium increases numbers of Foxp3+ Treg cells and reduces arthritis severity and joint damage in an IL-10-dependent manner mediated by the intestinal microbiome
por: Laragione, Teresina, et al.
Publicado: (2023)

Epicutaneous immunotherapy in rhino-conjunctivitis and food allergies: a review of the literature
por: Esposito, Susanna, et al.
Publicado: (2018)

Epithelial-derived IL-18 regulates Th17 cell differentiation and Foxp3(+) Treg cell function in the intestine
por: Harrison, OJ, et al.
Publicado: (2015)

Induction of stable human FOXP3(+) Tregs by a parasite‐derived TGF‐β mimic
por: Cook, Laura, et al.
Publicado: (2021)

Effects of recombinant human interleukin-10 on Treg cells, IL-10 and TGF-β in transplantation of rabbit skin
por: LIU, KAI SHAN, et al.
Publicado: (2014)

Determinants of efficacy and safety in epicutaneous allergen immunotherapy: summary of three clinical trials
por: Senti, G, et al.
Publicado: (2015)

The roles of basophils, TSLP and IL-33 in food allergy following epicutaneous sensitisation
por: Yoshimoto, Tomohiro, et al.
Publicado: (2015)

CTLA-4 Modulates the Differentiation of Inducible Foxp3(+) Treg Cells but IL-10 Mediates Their Function in Experimental Autoimmune Encephalomyelitis
por: Verhagen, Johan, et al.
Publicado: (2014)

Leprosy Reactions Show Increased Th17 Cell Activity and Reduced FOXP3+ Tregs with Concomitant Decrease in TGF-β and Increase in IL-6
por: Saini, Chaman, et al.
Publicado: (2016)

Sophora flavescens Alkaloids and Corticosteroid Synergistically Augment IL-10/IL-5 Ratio with Foxp3-Gene-Epigenetic Modification in Asthma PBMCs
por: Song, Ying, et al.
Publicado: (2021)

IL-25 and IL-33 Contribute to Development of Eosinophilic Airway Inflammation in Epicutaneously Antigen-Sensitized Mice
por: Morita, Hideaki, et al.
Publicado: (2015)

FOXP3, IL-10, and TGF-β Genes Expression in Children with IgE-Dependent Food Allergy
por: Krogulska, Aneta, et al.
Publicado: (2010)

FoxP3 Tregs Response to Sublingual Allergen Specific Immunotherapy in Children Depends on the Manifestation of Allergy
por: Stelmaszczyk-Emmel, Anna, et al.
Publicado: (2015)

Evaluation of IL-6, FoxP3 Treg lymphocytes, intestinal barrier biomarkers and the use of synbiotics in obese adolescents: a pilot study
por: Aziz, Cylmara, et al.
Publicado: (2023)

IL-35 promotes CD4(+)Foxp3(+) Tregs and inhibits atherosclerosis via maintaining CCR5-amplified Treg-suppressive mechanisms
por: Shao, Ying, et al.
Publicado: (2021)

Intact skin and not stripped skin is crucial for the safety and efficacy of peanut epicutaneous immunotherapy (EPIT) in mice
por: Mondoulet, Lucie, et al.
Publicado: (2012)

IL-34 Actions on FOXP3(+) Tregs and CD14(+) Monocytes Control Human Graft Rejection
por: Bézie, Séverine, et al.
Publicado: (2020)

Enriched circulating and tumor-resident TGF-β(+) regulatory B cells in patients with melanoma promote FOXP3(+) Tregs
por: Harris, Robert J, et al.
Publicado: (2022)

Co-Expression of FOXP3FL and FOXP3Δ2 Isoforms Is Required for Optimal Treg-Like Cell Phenotypes and Suppressive Function
por: Sato, Yohei, et al.
Publicado: (2021)

Development of Type 1 Diabetes in Mice Is Associated with a Decrease in IL-2-Producing ILC3 and FoxP3(+) Treg in the Small Intestine
por: Saksida, Tamara, et al.
Publicado: (2023)

Schistosoma mansoni-Mediated Suppression of Allergic Airway Inflammation Requires Patency and Foxp3(+) Treg Cells
por: Layland, Laura E., et al.
Publicado: (2013)

NAD(+) regulates Treg cell fate and promotes allograft survival via a systemic IL-10 production that is CD4(+) CD25(+) Foxp3(+) T cells independent
por: Elkhal, Abdallah, et al.
Publicado: (2016)

Plasmodium falciparum–Mediated Induction of Human CD25(hi)Foxp3(hi) CD4 T Cells Is Independent of Direct TCR Stimulation and Requires IL-2, IL-10 and TGFβ
por: Scholzen, Anja, et al.
Publicado: (2009)

BTLA-Expressing Dendritic Cells in Patients With Tuberculosis Exhibit Reduced Production of IL-12/IFN-α and Increased Production of IL-4 and TGF-β, Favoring Th2 and Foxp3(+) Treg Polarization
por: Zhang, Jun-Ai, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3vro6flg6nod656ejhi6j2f0e5